CRADA "Reasonable Price" Clause Becomes Part Of HHS Approps Bill
Executive Summary
"Reasonable" pricing for drugs developed with federal funding is closer to making a comeback with passage of an amendment to the fiscal 2001 Labor/HHS/ Education appropriations bill in the House.
You may also be interested in...
NIH Royalty Plan Due March 31 Under Wyden Amendment To Funding Bill
The National Institutes of Health would be directed to develop a plan to ensure a "reasonable rate of return" on taxpayer funded research under an amendment to the Senate Labor/HHS appropriations bill.
NIH Royalty Plan Due March 31 Under Wyden Amendment To Funding Bill
The National Institutes of Health would be directed to develop a plan to ensure a "reasonable rate of return" on taxpayer funded research under an amendment to the Senate Labor/HHS appropriations bill.
Jeffords Rx Re-Importation Bill Gains Sen. Gorton's Support
Sen. Jeffords' (R-Vt.) prescription drug re-importation bill has gained the support of another border-state Republican: Sen. Gorton of Washington.